Table 2.
S. No. | Therapeutic Approach | Phylum/Genus or the Name of Particular Bacteria | Neurological Disorder | References |
---|---|---|---|---|
1. | Recolonization of beneficial bacteria | Oral administration of Bacteroides fragilis | Experimental autoimmune encephalomyelitis | [174] |
2. | Fecal microbiota transplantation | Fecal microbiota suspension was injected through a TET tube. | Parkinson’s disease | [175] |
3. | Bacteriotherapy | Transcolonoscopic infusion of 13 non-pathogenic enteric bacteria | Chronic Fatigue Syndrome (CFS) | [176] |
4. | Administration of human commensal bacteria | Bacteroides fragilis | MIA mouse model of ASD (autism spectrum disorder) | [177] |
5. | Probiotic supplementation | Lactobacillus acidophilus, L. fermentum, Bifidobacterium lactis | Alzheimer’s disease | [178] |
6. | Fecal microbiota transplantation | FMT from healthy uninjured mice | Spinal cord injury (SCI) mice model | [179] |
7. | Probiotic supplementation | Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI | Alzheimer’s disease | [180] |
8. | Probiotic supplementation | Bifidobacterium infantis | Rat maternal separation (MS) model of depression | [181] |
9. | Fecal microbiota transplantation | Fecal suspension injected into the colon through the catheters | Traumatic brain injury (TBI) in male Sprague Dawley rats | [182] |
10. | Probiotic supplementation |
Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus helveticus, |
Alzheimer’s disease triple-transgenic mice | [183] |